The immune system is then in this early pathology down-regulated through the production of antiinflammatory immune molecules; specifically, the characteristic mediators of Th2-type T-cell responses (interferon IL-4, IL-5, IL-10) and antibodies of the Immunoglobin G4 (non-complement-fixing) subclass that serve as blocking antibodies.